American Healthcare REIT (NYSE:AHR) Price Target Raised to $37.00

American Healthcare REIT (NYSE:AHR) had its price target boosted by Morgan Stanley from $36.00 to $37.00 in a report published on Tuesday,Benzinga reports. The firm currently has an overweight rating on the stock.

Several other research firms have also issued reports on AHR. Royal Bank of Canada reissued an “outperform” rating and issued a $34.00 price target on shares of American Healthcare REIT in a research report on Wednesday, March 19th. Citigroup reissued an “outperform” rating on shares of American Healthcare REIT in a report on Tuesday, March 4th. Finally, JMP Securities set a $35.00 price target on American Healthcare REIT in a report on Tuesday, March 4th. Seven analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, American Healthcare REIT currently has an average rating of “Buy” and an average target price of $32.17.

American Healthcare REIT Stock Down 0.5 %

AHR opened at $30.31 on Tuesday. American Healthcare REIT has a twelve month low of $12.81 and a twelve month high of $30.97. The company’s 50-day moving average price is $28.88 and its two-hundred day moving average price is $27.46. The stock has a market cap of $4.78 billion and a price-to-earnings ratio of -63.15. The company has a quick ratio of 0.37, a current ratio of 0.37 and a debt-to-equity ratio of 0.59.

American Healthcare REIT Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, April 17th. Stockholders of record on Monday, March 31st will be given a dividend of $0.25 per share. The ex-dividend date is Monday, March 31st. This represents a $1.00 dividend on an annualized basis and a dividend yield of 3.30%. American Healthcare REIT’s dividend payout ratio (DPR) is currently -370.37%.

Institutional Investors Weigh In On American Healthcare REIT

Institutional investors and hedge funds have recently made changes to their positions in the business. Charles Schwab Investment Management Inc. increased its stake in American Healthcare REIT by 118.4% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,907,986 shares of the company’s stock worth $49,798,000 after acquiring an additional 1,034,365 shares during the last quarter. Janus Henderson Group PLC increased its position in shares of American Healthcare REIT by 79.8% in the third quarter. Janus Henderson Group PLC now owns 94,112 shares of the company’s stock worth $2,456,000 after purchasing an additional 41,755 shares during the last quarter. Swiss National Bank raised its stake in American Healthcare REIT by 126.6% in the third quarter. Swiss National Bank now owns 291,400 shares of the company’s stock valued at $7,606,000 after purchasing an additional 162,800 shares in the last quarter. Geneos Wealth Management Inc. bought a new stake in American Healthcare REIT during the fourth quarter valued at approximately $758,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in shares of American Healthcare REIT by 407.8% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 356,497 shares of the company’s stock worth $9,305,000 after acquiring an additional 286,292 shares during the last quarter. Hedge funds and other institutional investors own 16.68% of the company’s stock.

About American Healthcare REIT

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.